Can Remote Patient Monitoring Curb COVID-19?

BioIntelliSense’s BioSticker wearable sensor for monitoring patient vital signs remotely could prove useful during the COVID-19 pandemic. FDA cleared early this year to continuously monitor a patient’s respiratory rate, heart rate, and skin temperature, BioSticker can now also measure the frequency of a patient's coughing, sneezing, and vomiting, Jim Mault, CEO of BioIntelliSense, told MD+DI. In addition, “the BioIntelliSense Data Service in combination with the FDA-cleared BioSticker remote monitoring device and 5G-enabled BioHub allows for continuous health data for earlier, proactive clinical interventions,” he said. According to guidance from the Centers for Disease Control and Prevention (CDC), the hallmark symptoms of COVID-19 include fever, coughing, and shortness of breath, Mault explained. “These are the signs our BioSticker can monitor,” he said. “A multitude of health systems are asking for initial sets of BioSticker and BioHub for testing.” Mault emphasized that while the “vast majority of people who get COVID-19 will be fine,” there is “a small number of very high-risk, vulnerable patients.” He describes them as patients who are 70 years and older and also have significant chronic disease, such as heart failure and emphysema. “A lot ...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Source Type: news